trated in vacuo at low temperature. The residue was used directly
in the next step without further purification.
70.4, 69.1, 68.7, 68.0, 57.1, 20.9. [R]20 ) +106 (c 0.5, CHCl3).
D
Anal. Calcd for C23H28O7‚1/2H2O: C, 64.93; H, 6.87. Found: C,
64.98; H, 7.08.
General Inversion of Triflate Derivatives. KNO2 (5 equiv) was
added to a solution of the protected triflate residue (20 mg) in dry
DMF (2.0 mL). After stirring at 50 °C for 1-6 h, the mixture was
diluted with CH2Cl2 and washed with brine. The organic phase was
dried with MgSO4 and concentrated in vacuo. Purification of the
residue by flash column chromatography (5:2, hexanes-ethyl
acetate) afforded the inversion products.
Methyl 3-O-Acetyl-2,6-di-O-benzyl-â-D-gulopyranoside (13).
1H NMR (CDCl3, 400 MHz): δ 7.25-7.36 (m, 10H, 2 × OBn),
5.61 (t, 1H, J2,3, J3,4 ) 3.1 Hz, H3), 4.65 (s, 2H, OCH2C6H5), 4.64
(d, 1H, J1,2 ) 7.6 Hz, H1), 4.61, 4.51 (d, 2H, Ja,b ) 12.1 Hz,
OCHaHbC6H5), 3.70-3.86 (m, 4H, H4, H5, H6a, H6b), 3.53 (s, 3H,
OMe), 3.34 (dd, 1H, J1,2 ) 7.6 Hz, J2,3 ) 3.1 Hz, H2), 2.62 (d, 1H,
J ) 4.53 Hz, OH), 2.14 (s, 3H, OAc). 13C NMR (CDCl3, 100
MHz): δ 171.0, 137.7, 137.6, 128.5, 128.4, 127.9, 127.8, 127.7,
1
Methyl 2,4,6-Tri-O-acetyl-â-D-gulopyranoside (2). H NMR
(CDCl3, 400 MHz): δ 4.98 (dd, 1H, J3,4 ) 3.9 Hz, J4,5 ) 1.6 Hz,
H4), 4.93 (dd, 1H, J1,2 ) 8.1 Hz, J2,3 ) 3.1 Hz, H2), 4.74 (d, 1H,
J1,2 ) 8.1 Hz, H1), 4.30 (td, 1H, J4,5 ) 1.6 Hz, J5,6 ) 6.5 Hz, H5),
4.14-4.33 (m, 3H, H3, H6a, H6b), 3.51 (s, 3H, OMe.), 2.13 (s, 3H,
OAc), 2.12 (s, 3H, OAc), 2.05 (s, 3H, OAc). 13C NMR (CDCl3,
125 MHz): δ 170.6, 170.2, 169.5, 99.1, 70.5, 69.9, 69.5, 67.6, 61.9,
56.8, 21.0, 20.8, 20.7. [R]20D ) -103 (c 2.0, CHCl3). Anal. Calcd
for C13H20O9‚1/2H2O: C, 47.42; H, 6.43. Found: C, 47.49; H, 6.42.
Methyl 2,4,6-Tri-O-benzoyl-â-D-gulopyranoside (4). 1H NMR
(CDCl3, 400 MHz): δ 7.38-8.14 (m, 15H, 3 × OBz), 5.43 (dd,
1H, J ) 4.0 Hz, J ) 1.0 Hz, H4), 5.30 (dd, 1H, J1,2 ) 8.0 Hz, J2,3
) 3.1 Hz, H2), 5.03 (d, 1H, J1,2 ) 8.0 Hz, H1), 4.59-4.68 (m, 2H,
H6a, H6b), 4.44-4.52 (m, 2H, H3, H5), 3.58 (s, 3H, OMe). 13C NMR
(CDCl3, 125 MHz): δ 166.1 165.5 165.2, 133.6, 133.5, 133.1,
130.0, 129.8, 129.7, 129.6, 129.5, 129.0, 128.6, 128.5, 128.4, 99.5,
101.4, 75.8, 73.7, 72.5, 72.3, 70.6, 70.5, 68.8, 56.9, 21.0. [R]20
)
D
-116 (c 0.5, CHCl3). HRMS for C23H28O7‚Na, 439.1733; found,
439.1723.
Methyl 3-O-Acetyl-2,6-di-O-benzyl-â-D-glucopyranoside (14).
1H NMR (CDCl3, 500 MHz): δ 7.25-7.36 (m, 10H, 2 × OBn),
4.97 (t, 1H, J2,3, J3,4 ) 9.3 Hz, H3), 4.83, 4.60, 4.59, 4.56 (d, 4H,
Ja,b ) 12.1 Hz, 2 × OCHaHbC6H5), 4.36 (d, 1H, J1,2 ) 7.9 Hz,
H1), 3.76 (dd, 2H, J ) 4.57 Hz, J ) 3.0 Hz, H6), 3.61 (td, 1H, J4,3
) 9.3 Hz, J ) 3.8 Hz, H4), 3.56 (s, 3H, OMe), 3.46-3.51 (m, 1H,
H5), 3.33 (dd, 1H, J2,1 ) 7.9 Hz, J2,3 ) 9.3 Hz, H2), 2.92 (d, 1H,
J ) 3.8 Hz, OH), 2.00 (s, 3H, OAc). 13C NMR (CDCl3, 125
MHz): δ 171.8, 138.3, 137.7, 128.4, 128.3, 127.9, 127.8, 127.7,
127.6, 104.5, 78.7, 77.2, 74.2, 74.1, 73.7, 71.0, 70.1, 57.2, 21.0.
[R]20 ) +21 (c 4.0, CHCl3). Anal. Calcd for C23H28O7‚1/2H2O:
D
71.3, 70.7, 70.1, 68.0, 62.6, 57.0. [R]20 ) +20 (c 1.0, CHCl3).
C, 64.93; H, 6.87. Found: C, 65.42; H, 7.01.
D
Anal. Calcd for C28H26O9: C, 66.40; H, 5.17. Found: C, 66.22; H,
5.08.
Methyl 3-O-Acetyl-2,6-di-O-benzyl-â-D-galactopyranoside (15).
1H NMR (CDCl3, 400 MHz): δ 7.26-7.36 (m, 10H, 2 × OBn),
4.88 (dd, 1H, J2,3 ) 10.20 Hz, J3,4 ) 3.2 Hz, H3), 4.84, 4.61, 4.59,
4.55 (d, 4H, Ja,b ) 12.0 Hz, 2 × OCHaHbC6H5), 4.35 (d, 1H, J1,2
) 7.8 Hz, H1), 4.11 (t, 1H, J3,4, J4,5 ) 3.25 Hz, H4), 3.61-3.81
(m, 4H, H2, H5, H6a, H6b), 3.58 (s, 3H, OMe), 2.65 (d, 1H, J ) 4.3
Hz, OH), 2.04 (s, 3H, OAc). 13C NMR (CDCl3, 125 MHz): δ 170.3,
138.3, 137.5, 128.5, 128.3, 127.9, 127.8, 127.6, 105.0, 76.6, 74.7,
Methyl 4-O-Acetyl-2,6-di-O-benzyl-â-D-glucopyranoside (11).
1H NMR (CDCl3, 400 MHz): δ 7.25-7.36 (m, 10H, 2 × OBn),
4.79-4.86 (m, 1H, H4), 4.85, 4.59, 4.50, 4.45 (d, 4H, Ja,b ) 12.0
Hz, 2 × OCHaHbC6H5), 4.25 (d, 1H, J1,2 ) 7.6 Hz, H1), 3.60 (td,
1H, J2,3 ) 9.2 Hz, J3,4 ) 2.8 Hz, H3), 3.45-3.55 (m, 3H, H5, H6a,
H6b), 3.57 (s, 3H, OMe), 3.22 (dd, 1H, J1,2 ) 7.6 Hz, J2,3 ) 9.2
Hz, H2), 2.33 (d, 1H, J ) 2.8 Hz, OH), 1.98 (s, 3 H, OAc). 13C
NMR (CDCl3, 100 MHz): δ 170.4, 138.2, 137.8, 128.5, 128.4,
128.1, 127.9, 127.8, 127.7, 104.2, 81.2, 74.4, 74.2, 73.6, 73.4, 71.1,
73.8, 72.6, 69.5, 68.4, 57.2, 21.0. [R]20 ) +88 (c 0.5, CHCl3).
D
Anal. Calcd for C23H28O7: C, 66.33; H, 6.78. Found: C, 66.11; H,
7.02.
69.2, 57.1, 20.9. [R]20 ) +66 (c 0.5, CHCl3). Anal. Calcd for
D
C23H28O7‚1/2H2O: C, 64.93; H, 6.87. Found: C, 64.85; H, 6.87.
Methyl 4-O-Acetyl-2,6-di-O-benzyl-â-D-gulopyranoside (12).
1H NMR (CDCl3, 500 MHz): δ 7.25-7.36 (m, 10H, 2 × OBn),
4.83 (dd, 1H, J3,4 ) 2.8 Hz, J4,5 ) 9.7 Hz, H4), 4.81, 4.65, 4.61,
4.47 (d, 4H, Ja,b ) 12.0 Hz, 2 × OCHaHbC6H5), 4.68 (d, 1H, J1,2
) 7.6 Hz, H1), 4.34 (t, 1H, J2,3, J3,4 ) 2.8 Hz, H3), 4.08 (m, 1H,
H5), 3.51-3.64 (m, 2H, H6a, H6b), 3.56 (s, 3H, OMe), 3.34 (dd,
1H, J1,2 ) 7.6 Hz, J2,3 ) 2.8 Hz, H2), 2.48 (s, 1H, OH), 1.97 (s,
3H, OAc). 13C NMR (CDCl3, 125 MHz): δ 169.9, 138.1, 137.7,
128.5, 128.3, 128.0, 127.9, 127.8, 127.6, 101.6, 77.1, 73.4, 73.0,
Acknowledgment. This study was supported by the Swedish
Research Council, the Swedish Foundation for International
Cooperation in Research and Higher Education, the Royal
Institute of Technology, and the Carl Trygger Foundation.
Supporting Information Available: General methods, 1H and
13C spectra of compound 13. This material is available free of charge
JO052662I
J. Org. Chem, Vol. 71, No. 8, 2006 3309